This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA consultant Becky Davis was interviewed at Asembia AXS25 Summit to highlight her presentation titled “GLP-1s: Riding the Wave of Innovative Medications.”
Davis shared insights on navigating the evolving landscape of weight loss drugs, predicting market shifts and addressing insurance challenges. She highlighted the rising demand and expanding indications that are bringing GLP-1s into the spotlight.
Watch the interviews here: Pharmacy Times, Managed Healthcare Executive, and Drug Topics.
However, current levels of policy development do not reflect the urgency for change, especially given the progress made in understanding the disease and new...
In this CRA Insights, we assess the actions and impact of the second Trump Administration during the first 100 days that directly affect healthcare policy,...
CRA is a proud sponsor of the conference that aims to increase the prominence of women through professional development, substantive legal discussion, and...
CRA is a proud sponsor of the conference focusing on the intersection of intellectual property and the biopharmaceutical industry, and will explore the law,...
